2026 is highlighted as the year of the singularity with Elon Musk warning of underestimated impacts; conversations with him ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Engineers at the University of California have developed a new data structure and compression technique that enables the ...

The world’s most powerful supercomputers can now run simulations of billions of neurons, and researchers hope such models ...

MIT’s Recursive Language Models rethink AI memory by treating documents like searchable environments, enabling models to ...

AI coding tools are rapidly changing how we produce software, and the industry is embracing it—perhaps at the expense of ...

A University of Utah research team's rare find in a storage closet is being called a huge, historically significant discovery ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

CloseMate today opened early access for the world's first Fully Autonomous CRM powered by AGI-grade logic, introducing a ...

For almost a century, Science News journalists have covered advances in science, medicine and technology for the general public, including the 1925 Scopes “monkey” trial, the advent of the atomic age ...

Behavioral economist Katy Milkman explains why most New Year’s resolutions fail and shares how science-backed strategies can build habits that last. From Agency Chaos to Dark Energy Shocks: How ...